Somewhat Favorable News Coverage Somewhat Unlikely to Impact DENTSPLY SIRONA (XRAY) Share Price
News articles about DENTSPLY SIRONA (NASDAQ:XRAY) have trended somewhat positive on Wednesday, Accern reports. Accern ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. DENTSPLY SIRONA earned a daily sentiment score of 0.11 on Accern’s scale. Accern also gave media coverage about the medical instruments supplier an impact score of 47.2049787118407 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
These are some of the news headlines that may have effected Accern Sentiment’s analysis:
- Shares of Dentsply Sirona Fall Below Previous 52-Week Low (mysmartrend.com)
- DENTSPLY SIRONA Inc (NASDAQ:XRAY) Investor Investigation over Possible Violations of Securities Laws (digitaljournal.com)
- INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Dentsply Sirona, Inc. Investors (finance.yahoo.com)
- INVESTOR ALERT: Goldberg Law PC Announces an Investigation of DENTSPLY SIRONA Inc. (finance.yahoo.com)
- Zacks Investment Research Downgrades DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to Sell (americanbankingnews.com)
XRAY has been the subject of a number of recent research reports. UBS AG reissued a “neutral” rating and set a $59.00 price target (down from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. BidaskClub downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Stifel Nicolaus reissued a “buy” rating and set a $66.00 price target (down from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday. Finally, Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $66.25.
Shares of DENTSPLY SIRONA (NASDAQ:XRAY) opened at 53.76 on Wednesday. The company’s market cap is $12.34 billion. The firm has a 50-day moving average of $62.34 and a 200 day moving average of $62.34. DENTSPLY SIRONA has a 52 week low of $53.21 and a 52 week high of $65.68.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The firm had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. During the same quarter last year, the business earned $0.76 EPS. The company’s revenue was down 2.9% compared to the same quarter last year. Equities analysts anticipate that DENTSPLY SIRONA will post $2.72 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be issued a dividend of $0.0875 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 annualized dividend and a yield of 0.65%. DENTSPLY SIRONA’s payout ratio is -10.09%.
ILLEGAL ACTIVITY WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact DENTSPLY SIRONA (XRAY) Share Price” was posted by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.watchlistnews.com/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-dentsply-sirona-xray-share-price/1492816.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.